Top Markets
#1 DogBull DogBull +108.52%
#2 MarsCoin MarsCoin +77.08%
#3 Siacoin Siacoin +54.30%
#4 ADO Protocol ADO Protocol +52.57%
#5 The Bitcoin Bull The Bitcoin Bull +28.16%
#6 Ontology Gas Ontology Gas +25.60%
#7 Apertum Apertum +16.37%
#8 Pons Pons +14.02%
#9 Useless Coin Useless Coin +13.13%
#10 Arowana Arowana +12.73%
Coin of the day
DogBull DogBull
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Australian Clinical Labs Limited Australian Clinical Labs Limited

Australian Clinical Labs Limited

ACL
Classifica tra le azioni #15163
Australian Clinical Labs Limited operates across Australia, delivering a... Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening. Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services. ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial drug and alcohol screening. These essential services are supplied to both private and public hospitals throughout the nation. The company was founded in 2020 and maintains its primary operational base in Clayton, Australia.
Prezzo delle azioni
$1.98
Capitalizzazione di mercato
$368.99M
Variazione (1 giorno)
0.90%
Variazione (1 anno)
11.38%
Paese
AU
Scambia Australian Clinical Labs Limited (ACL)

Categoria

Healthcare
Ricavi di Australian Clinical Labs Limited (ACL)
Ricavi nel Sep 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Australian Clinical Labs Limited, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Australian Clinical Labs Limited da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B -
US